Decide rationale/design: daclizumab high yield process monotherapy in relapsing remitting multiple sclerosis (RRMS)
Author
Elkins, J.
Eraksoy, M.
Boyko, A.
Sheridan, J.
O'Neil, G.
Kappos, L.
Wiendl, H.
Kaufman, M.
Rose, J.
Havrdova, E.
Metadata
Show full item recordCollections
- Bildiri [64839]